MPEP § 2419 — Publishing of Patent Grants and Patent Application Publications with a “Sequence Listing XML” (Annotated Rules)
§2419 Publishing of Patent Grants and Patent Application Publications with a “Sequence Listing XML”
This page consolidates and annotates all enforceable requirements under MPEP § 2419, including statutory authority, regulatory rules, examiner guidance, and practice notes. It is provided as guidance, with links to the ground truth sources. This is information only, it is not legal advice.
Publishing of Patent Grants and Patent Application Publications with a “Sequence Listing XML”
This section addresses Publishing of Patent Grants and Patent Application Publications with a “Sequence Listing XML”.
Key Rules
Sequence Listing Content
[Editor Note: This section is applicable to all applications with a filing date, or, for national phase applications, an international filing date, on or after July 1, 2022, having disclosure of one or more nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).]
Citations
| Primary topic | Citation |
|---|---|
| Sequence Listing Content | 37 CFR § 1.831(b) |
Source Text from USPTO’s MPEP
This is an exact copy of the MPEP from the USPTO. It is here for your reference to see the section in context.
Official MPEP § 2419 — Publishing of Patent Grants and Patent Application Publications with a “Sequence Listing XML”
Source: USPTO2419 Publishing of Patent Grants and Patent Application Publications with a “Sequence Listing XML” [R-01.2024]
[Editor Note: This section is applicable to all applications with a filing date, or, for national phase applications, an international filing date, on or after July 1, 2022, having disclosure of one or more nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).]
At the USPTO, the Sequence Listing Information Control (SLIC) system is responsible for processing of a “Sequence Listing XML” and exporting the sequence data for publication and grant. Because a “Sequence Listing XML” exists only in .xml file format, the USPTO uses a style sheet to transform a “Sequence Listing XML” file of less than 1 GB in size into an ASCII text file which will be used to present the sequence information in a format that is more easily read.